Biblio
“Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 2, pp. 813-825, 2023.
, “Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 863-881, 2020.
, “Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 69, no. 3, pp. 751-762, 2019.
, “Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 551-561, 2018.
, “A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1459-1468, 2017.
, “Polymorphonuclear Neutrophil Functions are Differentially Altered in Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 60, no. 1, pp. 23-42, 2017.
, “Anti-Viral Properties of Amyloid-β Peptides.”, J Alzheimers Dis, vol. 54, no. 3, pp. 859-878, 2016.
, “Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1227-41, 2016.
,